<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Radiotherapy for diffuse brainstem glioma in children and young adults - Hu, X - 2016 | Cochrane Library</title> <meta content="Radiotherapy for diffuse brainstem glioma in children and young adults - Hu, X - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010439.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Radiotherapy for diffuse brainstem glioma in children and young adults - Hu, X - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010439.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010439.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Radiotherapy for diffuse brainstem glioma in children and young adults" name="citation_title"/> <meta content="Xin Hu" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Yuan Fang" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Xuhui Hui" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Yan Jv" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="Chao You" name="citation_author"/> <meta content="West China Hospital, Sichuan University" name="citation_author_institution"/> <meta content="youchao_nswc@163.com" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD010439.pub2" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/06/27" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010439.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010439.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010439.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Brain Stem; *Dose Fractionation, Radiation; Brain Neoplasms [mortality, pathology, *radiotherapy]; Glioma [mortality, pathology, *radiotherapy]; Neoplasm Invasiveness; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010439.pub2&amp;doi=10.1002/14651858.CD010439.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="uQyIsxpV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010439\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010439\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010439.pub2",title:"Radiotherapy for diffuse brainstem glioma in children and young adults",firstPublishedDate:"Jun 27, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Childhood Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010439.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010439.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010439.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010439.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010439.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010439.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010439.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010439.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010439.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010439.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2460 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010439.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-sec-0081"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-sec-0017"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-sec-0018"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-sec-0044"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-sec-0075"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/appendices#CD010439-sec-0086"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/table_n/CD010439StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/table_n/CD010439StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Radiotherapy for diffuse brainstem glioma in children and young adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/information#CD010439-cr-0002">Xin Hu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/information#CD010439-cr-0003">Yuan Fang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/information#CD010439-cr-0004">Xuhui Hui</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/information#CD010439-cr-0005">Yan Jv</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010439.pub2/information#CD010439-cr-0006"><i class="icon corresponding-author fa fa-envelope"></i>Chao You</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/information/en#CD010439-sec-0093">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 27 June 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010439.pub2">https://doi.org/10.1002/14651858.CD010439.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010439-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010439-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010439-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010439-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010439-abs-0001" lang="en"> <section id="CD010439-sec-0001"> <h3 class="title" id="CD010439-sec-0001">Background</h3> <p>Diffuse brainstem glioma is a devastating disease with very poor prognosis. The most commonly used radiological treatment is conventional fractionated radiation. So far, there is no meta‐analysis or systematic review available that assesses the benefits or harms of radiation in people with diffuse brainstem glioma. </p> </section> <section id="CD010439-sec-0002"> <h3 class="title" id="CD010439-sec-0002">Objectives</h3> <p>To assess the effects of conventional fractionated radiotherapy (with or without chemotherapy) versus other therapies (including different radiotherapy techniques) for newly diagnosed diffuse brainstem gliomas in children and young adults aged 0 to 21 years. </p> </section> <section id="CD010439-sec-0003"> <h3 class="title" id="CD010439-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE/PubMed, and EMBASE to 19 August 2015. We scanned conference proceedings from the International Society for Paediatric Oncology (SIOP), International Symposium on Paediatric Neuro‐Oncology (ISPNO), Society of Neuro‐Oncology (SNO), and European Association of Neuro‐Oncology (EANO) from 1 January 2010 to 19 August 2015. We searched trial registers including the International Standard Randomised Controlled Trial Number (ISRCTN) Register, the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), and the register of the National Institutes of Health to 19 August 2015. We imposed no language restrictions. </p> </section> <section id="CD010439-sec-0004"> <h3 class="title" id="CD010439-sec-0004">Selection criteria</h3> <p>All randomised controlled trials (RCTs), quasi‐randomised trials (QRCTs), or controlled clinical trials (CCTs) that compared conventional fractionated radiotherapy (with or without chemotherapy) versus other therapies (including different radiotherapy techniques) for newly diagnosed diffuse brainstem glioma in children and young adults aged 0 to 21 years. </p> </section> <section id="CD010439-sec-0005"> <h3 class="title" id="CD010439-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened studies for inclusion, extracted data, assessed the risk of bias in each eligible trial, and conducted GRADE assessment of included studies. We resolved disagreements through discussion. We performed analyses according to the guidelines of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>. </p> </section> <section id="CD010439-sec-0006"> <h3 class="title" id="CD010439-sec-0006">Main results</h3> <p>We identified two RCTs that fulfilled our inclusion criteria. The two trials tested different comparisons. </p> <p>One multi‐institutional RCT included 130 participants and compared hyperfractionated radiotherapy (six‐week course with twice a day treatment of 117 cGy per fraction to a total dose of 7020 cGy) with conventional radiotherapy (six‐week course with once a day treatment of 180 cGy per fraction to a total dose of 5400 cGy). The median time overall survival (OS) was 8.5 months in the conventional group and 8.0 months in the hyperfractionated group. We detected no clear evidence of effect on OS or event‐free survival (EFS) in participants receiving hyperfractionated radiotherapy compared with conventional radiotherapy (OS: hazard ratio (HR) 1.07, 95% confidence interval (CI) 0.75 to 1.53; EFS: HR 1.26, 95% CI 0.83 to 1.90). Radiological response (risk ratio (RR) 0.94, 95% CI 0.54 to 1.63) and various types of toxicities were similar in the two groups. There was no information on other outcomes. According to the GRADE approach, we judged the quality of evidence to be low (i.e. further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate) for OS and EFS, and very low (i.e. we are very uncertain about the estimate) for radiological response and toxicities. </p> <p>The second RCT included 71 participants and compared hypofractionated radiotherapy (39 Gy in 13 fractions over 2.6 weeks, 3 Gy per fraction) with conventional radiotherapy (54 Gy in 30 fractions over six weeks, 1.8 Gy per fraction). This trial reported a median OS of 7.8 months for the hypofractionated group and 9.5 months for the conventional group. It reported a progression‐free survival (PFS) of 6.3 months for the hypofractionated group and 7.3 months for the conventional group. We found no clear evidence of effect on OS (HR 1.03, 95% CI 0.53 to 2.01) or PFS (HR 1.19, 95% CI 0.63 to 2.22) in participants receiving hypofractionated radiotherapy when compared with participants receiving conventional radiotherapy. The mainly observed adverse effect was local erythema and dry desquamation especially behind the auricles. There were some other toxicities, but there was no statistically significant difference between treatment groups. There was no information on other outcomes. We judged the quality of evidence to be moderate (i.e. further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate) for OS, and low for PFS and toxicities. It should be mentioned that the sample size in this RCT was small, which could lead to insufficient statistical power for a clinically relevant outcome. </p> </section> <section id="CD010439-sec-0007"> <h3 class="title" id="CD010439-sec-0007">Authors' conclusions</h3> <p>We could make no definitive conclusions from this review based on the currently available evidence. Further research is needed to establish the role of radiotherapy in the management of newly diagnosed diffuse brainstem glioma in children and young adults. Future RCTs should be conducted with adequate power and all relevant outcomes should be taken into consideration. Moreover, international multicentre collaboration is encouraged. Considering the potential advantage of hypofractionated radiotherapy to decrease the treatment burden and increase the quality of remaining life, we suggest that more attention should be paid to hypofractionated radiotherapy. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010439-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010439-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010439-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010439-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010439-abs-0004">Hrvatski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010439-abs-0003" lang="en"> <h3>Radiotherapy for diffuse brainstem glioma in children and young adults</h3> <p><b>Review question</b> </p> <p>To assess the effects of conventional radiotherapy (with or without chemotherapy) versus other therapies (including different radiotherapy techniques) for newly diagnosed diffuse brainstem gliomas in children and young adults aged 0 to 21 years. </p> <p><b>Background</b> </p> <p>Diffuse brainstem glioma typically occurs in the pons (part of the brainstem) and expands and infiltrates at least 50% of the pons, with a characteristic appearance on magnetic resonance imaging (MRI). The prognosis is very poor, with a median overall survival (OS; time from cancer diagnosis, or treatment, to death from any cause) ranges from 8 to 11 months. So far, there is no analysis or review available that assessed the benefits or harms of radiation for newly diagnosed diffuse brainstem glioma in children and young adults aged 0 to 21 years. </p> <p><b>Study characteristics</b> </p> <p>Through comprehensive search and screening of medical databases, we found two clinical studies that tested different treatments. One study, with 130 participants included, compared hyperfractionated radiotherapy (six‐week course with treatment twice a day ) with conventional radiotherapy (six‐week course with treatment once a day ). The second study, with 71 participants included, compared hypofractionated radiotherapy (three‐week course with treatment once a day ) with conventional radiotherapy. </p> <p><b>Key results</b> </p> <p>For the comparison of hyperfractionated radiotherapy and conventional radiotherapy, there was no clear evidence of effect on OS, event‐free survival (EFS; time from diagnosis, study entry, or treatment to disease progression, disease relapse, a second tumour, or death), radiological response (a reduction in tumour size of more than 50%), and toxicities (damage to the body due to radiotherapy). </p> <p>For the comparison of hypofractionated radiotherapy and conventional radiotherapy, there was no clear evidence of effect on OS, progression‐free survival (PFS; time from diagnosis, study entry, or treatment to disease progression), and side effects. </p> <p><b>Quality of the evidence</b> </p> <p>For the hyperfractionated radiotherapy, when compared with conventional therapy, the quality of evidence was low for OS and EFS, and very low for radiological response and toxicities. </p> <p>For the hypofractionated radiotherapy, when compared with conventional therapy, the quality of evidence was moderate for OS, and low for PFS and toxicities. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010439-sec-0081" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010439-sec-0081">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010439-sec-0115">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010439-sec-0081"></div> <h3 class="title" id="CD010439-sec-0082">Implications for practice</h3> <section id="CD010439-sec-0082"> <p>We identified only two randomised controlled trials (RCTs) evaluating radiotherapy in newly diagnosed diffuse brainstem glioma in children and young adults aged 0 to 21 years. One RCT compared hyperfractionated versus conventional radiotherapy and was conducted from 1992 to 1997 (<a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a>). There was no clear evidence of effect of hyperfractionated radiotherapy with regard to overall survival (OS), event‐free survival (EFS), radiological response, and various types of toxicities. Considering the similar outcomes and treatment burden for participant and family as well as radiation oncology department, Mandell et al. recommended conventional radiotherapy as standard radiotherapy strategy. The second study compared hypofractionated versus conventional radiotherapy and was conducted from 2007 to 2013 (<a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>). There was no clear evidence of effect of hypofractionated radiotherapy on OS, progression‐free survival (PFS), or toxicities. Based on the results of this most recent trial, Zaghloul et al. recommended hypofractionated radiotherapy instead of conventional radiotherapy as standard radiotherapy due to the lesser time spent on treatment with minimal effect on survival rates. Neither study reported information on quality of life (QoL) and neurological response, and only one study reported radiological response. It should be noted that no evidence of effect, as identified in this review, is not the same as evidence of no effect. </p> </section> <h3 class="title" id="CD010439-sec-0083">Implications for research</h3> <section id="CD010439-sec-0083"> <p>Further research is needed to establish the role of radiotherapy in management of diffuse brainstem glioma in children and young adults. Future RCTs should be conducted with adequate power and all relevant outcomes should be taken into consideration, including OS, EFS, PFS, QoL, neurological response, radiological response, toxicities, and steroid consumption. Given the incidence of this rare entity, international multicentre collaboration is encouraged. Considering the potential advantage of hypofractionated radiotherapy to decrease the treatment burden and increase the quality of remaining life, we suggest that more attention should be given to hypofractionated radiotherapy. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010439-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010439-sec-0015"></div> <div class="table" id="CD010439-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hyperfractionated radiotherapy compared with conventional radiotherapy for diffuse brainstem glioma in children and young adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hyperfractionated radiotherapy compared with conventional radiotherapy for diffuse brainstem glioma in children and young adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children and young adults with diffuse brainstem glioma </p> <p><b>Settings:</b> hospital setting in USA and Canada </p> <p><b>Intervention:</b> hyperfractionated radiotherapy </p> <p><b>Comparison:</b> conventional radiotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Conventional radiotherapy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Hyperfractionated radiotherapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HR 1.07 (0.75 to 1.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time‐to‐event data; no assumed risk could be calculated</p> <p>Participants were enrolled between June 1992 and March 1996. All participants were followed until death or October 1997 except 5 participants who were lost during follow‐up </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Progression‐free survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adequate information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Event‐free survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HR 1.26 (0.83 to 1.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time‐to‐event data; no assumed risk could be calculated</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Neurological response</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adequate information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Radiological response</b> </p> <p>defined as the number of participants with a reduction in tumour size &gt; 50%</p> <p>Follow‐up: 4 or 8 weeks<br/> (median 4 weeks) post treatment </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>333 per 1000<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>313 per 1000<br/> (180 to 543) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.94 (0.54 to 1.63)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>108<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>2,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Toxicities</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112 or 113</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>2,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Various types of toxicities were evaluated (see text)</p> <p>No significant differences in examined toxicities between the 2 groups</p> <p>For fungal stomatitis, 112 participants were available while for the other toxicities, 113 participants were available </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>HR:</b> hazard ratio; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The assumed risk is based on the prevalence in the control group of the included study. </p> <p><sup>2</sup> Small sample size with a total number of events fewer than 300 (the threshold rule‐of‐thumb value stated in the GRADEpro software). </p> <p><sup>3</sup> Presence of selection bias and other bias was unclear. </p> <p><sup>4</sup> Presence of selection bias, detection bias, and other bias was unclear. </p> <p><sup>5</sup> Presence of selection bias, detection bias, and other bias was unclear; high risk of attrition bias. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010439-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Hypofractionated radiotherapy compared with conventional radiotherapy for diffuse brainstem glioma in children and young adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hypofractionated radiotherapy compared with conventional radiotherapy for diffuse brainstem glioma in children and young adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children and young adults with diffuse brainstem glioma </p> <p><b>Settings:</b> Children's Cancer Hospital, Egypt </p> <p><b>Intervention:</b> hypofractionated radiotherapy </p> <p><b>Comparison:</b> conventional radiotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Conventional radiotherapy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Hypofractionated radiotherapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall survival</b> </p> <p>Follow up: mean 9 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HR 1.03 (0.53 to 2.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> moderate<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time‐to‐event data; no assumed risk could be calculated</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Progression‐free survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HR 1.19 (0.63 to 2.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time‐to‐event data; no assumed risk could be calculated</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Event‐free survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Neurological response</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Radiological response</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Toxicities</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Various types of toxicities were evaluated (see text)</p> <p>No significant differences in examined toxicities between the 2 groups</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>HR:</b> hazard ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Small sample size with a total number of events fewer than 300 (the threshold rule‐of‐thumb value stated in the GRADEpro software). </p> <p><sup>2</sup> High risk of detection bias. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010439-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010439-sec-0016">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010439-sec-0099">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD010439-sec-0016"></div> <p>Gliomas located in the brainstem account for 10% to 20% of all brain tumours in children (<a href="./references#CD010439-bbs2-0043" title="StillerCA , NectouxJ . International incidence of childhood brain and spinal tumours. International Journal of Epidemiology1994;23:458‐64. ">Stiller 1994</a>; <a href="./references#CD010439-bbs2-0029" title="JalloGI , Biser‐RohrbaughA , FreedD . Brainstem gliomas. Child's Nervous System2004;20:143‐53. ">Jallo 2004</a>). Many classification schemes have been devised for brainstem tumours (<a href="./references#CD010439-bbs2-0028" title="JalloGI , FreedD , RoonprapuntC , EpsteinF . Current management of brainstem gliomas. Annals of Neurosurgery2003;3(1):1‐17. ">Jallo 2003</a>). Currently, radiographic findings and clinical symptoms are used to categorise brainstem gliomas into four groups, namely: diffuse (widely distributed), focal, exophytic (growing outwards from the epithelium), and cervicomedullary (within the organ) (<a href="./references#CD010439-bbs2-0042" title="RoonprapuntC , AbbottR . Surgical treatment of brainstem gliomas in children. Neurosurgery Quarterly2002;12(2):160‐70. ">Roonprapunt 2002</a>). Focal tumours are defined as demarcated lesions less than 2 cm in diameter without associated oedema; dorsally exophytic brainstem gliomas are a group of tumours arising from the subependymal glial tissue; and cervicomedullary brainstem gliomas are similar to intramedullary spinal cord gliomas. Focal and dorsally exophytic brainstem gliomas comprise about 15% to 20% of brainstem tumours; they are low‐grade astrocytomas (i.e. arise from embryonic tissue that forms the nervous system) that have characteristic clinical features, growth patterns of low‐grade glial tumours, and generally follow an indolent course (i.e. cause no trouble or pain). Most of the remaining 80% of tumours are diffuse brainstem gliomas (DBG) (<a href="./references#CD010439-bbs2-0036" title="MariaBL ,  RehderK ,  EskinTA ,  HamedLM ,  FennellEB ,  QuislingRG ,  etal . Brainstem glioma: I. Pathology, clinical features, and therapy. Journal of Child Neurology1993;8(2):112‐28. ">Maria 1993</a>); usually a fibrillary (World Health Organization (WHO) grade 2) or malignant (WHO grade 3 or 4) astrocytoma (<a href="./references#CD010439-bbs2-0022" title="FreemanCR , FarmerJP . Pediatric brain stem gliomas: a review. International Journal of Radiation Oncology, Biology, Physics1998;40(2):265‐71. ">Freeman 1998</a>). DBGs are the most aggressive subgroup of brainstem tumours, and typically occur in the pons (part of the brainstem) with a characteristic appearance on magnetic resonance imaging (MRI) of a T1 hypointensity and T2 hyperintensity diffuse tumour, which expands and infiltrates at least 50% of the pons. The encasement of the basilar artery is one of the most common findings in typical diffuse intrinsic pontine gliomas (DIPG) (<a href="./references#CD010439-bbs2-0025" title="HargraveD , ChuangN , BouffetE . Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma. Journal of Neuro‐Oncology2008;86(3):313‐9. ">Hargrave 2008</a>). The typical clinical presentation includes a neurological signs triad: multiple cranial nerve deficits (cranial neuropathy), long tract signs (hyper‐reflexia, a Babinski sign, and weakness), and ataxia (problems with muscular co‐ordination) (<a href="./references#CD010439-bbs2-0018" title="DonaldsonSS , LaninghamF , FisherPG . Advances toward an understanding of brainstem gliomas. Journal of Clinical Oncology2006;24(8):1266‐72. ">Donaldson 2006</a>; <a href="./references#CD010439-bbs2-0033" title="KhatuaS , MooreKR , VatsTS , KestleJR . Diffuse intrinsic pontine glioma‐current status and future strategies. Childs Nervous System2011;27(9):1391‐7. ">Khatua 2011</a>). </p> <p>Diffuse pontine (i.e. relating to the pons) gliomas rarely affect children younger than three years old. Broniscer et al. suggested that DBG in children below the age of three years may be distinct biologically from similar tumours in older age groups (<a href="./references#CD010439-bbs2-0015" title="BroniscerA ,  LaninghamFH ,  SandersRP ,  KunLE ,  EllisonDW ,  GajjarA . Young age may predict a better outcome for children with diffuse pontine glioma. Cancer2008;113(3):566‐72. ">Broniscer 2008</a>). The difference between children aged below three years and older children with diffuse pontine glioma is unclear. In addition, most contemporary clinical trials for children with diffuse pontine glioma are restricted to children aged three years and older. </p> <p>Despite collaborative efforts to improve treatments, DBGs carry the worst prognosis of all brainstem gliomas. Survival has remained dismal since the mid‐1990s with the median overall survival (OS) ranging from 8 to 14 months (<a href="./references#CD010439-bbs2-0032" title="KaplanAM , AlbrightAL , ZimmermanRA , RorkeLB , LiH , BoyettJM , et al. Brainstem gliomas in children. A Children's Cancer Group review of 119 cases. Pediatric Neurosurgery1996;24(4):185‐92. ">Kaplan 1996</a>; <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a>; <a href="./references#CD010439-bbs2-0045" title="VananMI , EisenstatDD . DIPG in children ‐ what can we learn from the past?. Frontiers in Oncology2015;5:237. ">Vanan 2015</a>). Various interventions have been investigated including radiation, surgical resection, chemotherapy, radiation sensitisers, and biological agents (<a href="./references#CD010439-bbs2-0019" title="EpsteinF ,  WisoffJH . Intrinsic brainstem tumors in childhood: surgical indications. Journal of Neuro‐Oncology1988;6(4):309‐17. ">Epstein 1988</a>; <a href="./references#CD010439-bbs2-0039" title="Pierre‐KahnA , HirschJF , VinchonM , PayanC , Sainte‐RoseC , RenierD , et al. Surgical management of brain‐stem tumors in children: results and statistical analysis of 75 cases. Journal of Neurosurgery1993;79(6):845‐52. ">Pierre‐Kahn 1993</a>; <a href="./references#CD010439-bbs2-0024" title="HargraveD ,  BartelsU ,  BouffetE . Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncology2006;7(3):241‐8. ">Hargrave 2006</a>; <a href="./references#CD010439-bbs2-0030" title="JansenMH , vanVuurdenDG , VandertopWP , KaspersGJ . Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treatment Reviews2012;38(1):27‐35. ">Jansen 2012</a>). However, most of them showed disappointing efficacy. Radiotherapy is the only treatment that has consistently shown clinical and radiographic improvement in people with DBG (<a href="./references#CD010439-bbs2-0033" title="KhatuaS , MooreKR , VatsTS , KestleJR . Diffuse intrinsic pontine glioma‐current status and future strategies. Childs Nervous System2011;27(9):1391‐7. ">Khatua 2011</a>). </p> <p>Without radiation, median survival is approximately 20 weeks (<a href="./references#CD010439-bbs2-0035" title="LangmoenIA , LundarT , Storm‐MathisenI , LieSO , HovindKH . Management of pediatric pontine gliomas. Child's Nervous System1991;7(1):13‐5. ">Langmoen 1991</a>). The most commonly used radiological treatment is conventional fractionated radiation, with local field radiation for a total dose of 54 to 60 Gy delivered in 30 fractions (1.8 to 2 Gy per fraction per day) over a period of six weeks (<a href="./references#CD010439-bbs2-0014" title="AlbrightAL , PollackIF . Brainstem gliomas. In: WinnHR editor(s). Youmans Neurological Surgery. Vol. 3, Philadelphia: Saunders, 2004:3663‐9. ">Albright 2004</a>; <a href="./references#CD010439-bbs2-0018" title="DonaldsonSS , LaninghamF , FisherPG . Advances toward an understanding of brainstem gliomas. Journal of Clinical Oncology2006;24(8):1266‐72. ">Donaldson 2006</a>). Preclinical studies have shown that initial radiation effects are mediated through direct vascular effects on the endothelium (i.e. thin layer of cells that lines the interior surface of blood vessels) and through cytokine (i.e. small cell‐signalling protein molecules that are secreted by cells) activation, with attendant oedema and disruption of the blood‐brain barrier. Doses delivered within the therapeutic range result in progressive, diffuse changes in white matter as part of a continuous, dynamic series of events, including direct and indirect effects on glial (brain tissue that does not conduct electrical impulses) and neuronal elements, as well as on small vessels (<a href="./references#CD010439-bbs2-0044" title="TofilonPJ , FikeJR . The radioresponse of the central nervous system: a dynamic process. Radiation Research2000;153(4):357‐70. ">Tofilon 2000</a>; <a href="./references#CD010439-bbs2-0016" title="CoderreJA , MorrisGM , MiccaPL , HopewellJW , VerhagenI , KleiboerBJ , et al. Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival. Radiation Research2006;166:495‐503. ">Coderre 2006</a>). Studies reported no toxicity in children with brainstem glioma (treated with opposed lateral fields that encompassed the majority of the brainstem) to doses of 54 to 60 Gy at 2 Gy per fraction, 75.6 Gy at 1.26 Gy twice daily, or 78 Gy at 1 Gy twice daily (<a href="./references#CD010439-bbs2-0004" title="FreemanCR , KrischerJP , SanfordRA , CohenME , BurgerPC , delCarpioR , et al. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. International Journal of Radiation Oncology, Biology, Physics1993;27(2):197‐206. ">Freeman 1993</a>; <a href="./references#CD010439-bbs2-0010" title="PackerR , BoyettJ , ZimmermanR , AlbrightA , KaplanA , RorkeL , et al. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy: a Children's Cancer Group phase I/II trial. Cancer1994;74(6):1827‐34. ">Packer 1994</a>; <a href="./references#CD010439-bbs2-0037" title="MayoC , YorkeE , MerchantTE . Radiation associated brainstem injury. International Journal of Radiation Oncology, Biology, Physics2010;76(3 Suppl):S36‐41. ">Mayo 2010</a>). Radiotherapy induces neurological improvement, allows reduction or discontinuation of steroids, and is associated with the radiological response. </p> <p>Researchers attempted to seek more effective radiotherapeutic approaches given the evidence of transient response to radiation, the tumours' tendencies to progress locally (<a href="./references#CD010439-bbs2-0017" title="DonahueB ,  AllenJ ,  SiffertJ ,  RosovskyM ,  PintoR . Patterns of recurrence in brain stem gliomas: evidence for craniospinal dissemination. International Journal of Radiation Oncology, Biology, Physics1998;40(3):677‐80. ">Donahue 1998</a>), and the radiation dose‐response relationship observed for DBGs (<a href="./references#CD010439-bbs2-0026" title="HibiT , ShitaraN , GenkaS , FuchinoueT , HayakawaI , TsuchidaT , et al. Radiotherapy for pediatric brain stem glioma: radiation dose, response, and survival. Neurosurgery1992;31(4):643‐50. ">Hibi 1992</a>). These regimens were designed to increase the dose‐intensity by delivering a higher total dose in the same time (hyperfractionated regimen) (<a href="./references#CD010439-bbs2-0021" title="FreemanCR ,  KrischerJ ,  SanfordRA ,  CohenME ,  BurgerPC ,  KunL ,  etal . Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495. Cancer1991;68(3):474‐81. ">Freeman 1991</a>; <a href="./references#CD010439-bbs2-0004" title="FreemanCR , KrischerJP , SanfordRA , CohenME , BurgerPC , delCarpioR , et al. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. International Journal of Radiation Oncology, Biology, Physics1993;27(2):197‐206. ">Freeman 1993</a>; <a href="./references#CD010439-bbs2-0010" title="PackerR , BoyettJ , ZimmermanR , AlbrightA , KaplanA , RorkeL , et al. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy: a Children's Cancer Group phase I/II trial. Cancer1994;74(6):1827‐34. ">Packer 1994</a>; <a href="./references#CD010439-bbs2-0040" title="PradosMD ,  WaraWM ,  EdwardsMS ,  LarsonDA ,  LambornK ,  LevinVA . The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. International Journal of Radiation Oncology, Biology, Physics1995;32(1):85‐91. ">Prados 1995</a>), or a higher daily dose given over a shorter period of time (hypofractionated regimen) (<a href="./references#CD010439-bbs2-0031" title="JanssensGO ,  GiddingCE ,  Van LindertEJ ,  OldenburgerFR ,  ErasmusCE ,  Schouten‐MeeterenAY ,  etal . The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study. International Journal of Radiation Oncology, Biology, Physics2009;73(3):722‐6. ">Janssens 2009</a>; <a href="./references#CD010439-bbs2-0007" title="NegrettiL , BouchirebK , Levy‐PiedboisC , HabrandJL , DhermainF , KalifaC . Hypofractionated radiotherapy in the treatment of diffuse intrinsic pontine glioma in children: a single institution's experience. Journal of Neuro‐Oncology2011;104(3):773‐7. ">Negretti 2011</a>). In hyperfractionated regimens, two fractions are delivered each day, with a reduced dose per fraction equal to 1.1 to 1.2 Gy. The reduction of the dose per fraction might reduce the risk of late toxicity, despite the increased total dose. In 1984, the Pediatric Oncology Group began a phase I/II study to test the efficacy and toxicity of sequentially escalated doses of hyperfractionated (twice daily) radiation in children with brainstem gliomas (<a href="./references#CD010439-bbs2-0020" title="FreemanCR ,  KrischerJ ,  SanfordRA ,  BurgerPC ,  CohenM ,  NorrisD . Hyperfractionated radiotherapy in brain stem tumors: results of a Pediatric Oncology Group study. International Journal of Radiation Oncology, Biology, Physics1988;15(2):311‐8. ">Freeman 1988</a>). The final results of this study revealed that there appeared to be a trend towards increased survival and time to progression with an increase in the dose level from 6600 to 7020 cGy (<a href="./references#CD010439-bbs2-0021" title="FreemanCR ,  KrischerJ ,  SanfordRA ,  CohenME ,  BurgerPC ,  KunL ,  etal . Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495. Cancer1991;68(3):474‐81. ">Freeman 1991</a>). The next dose escalation level of 7560 cGy did not result in an improvement in survival over that observed with the second dose level (<a href="./references#CD010439-bbs2-0004" title="FreemanCR , KrischerJP , SanfordRA , CohenME , BurgerPC , delCarpioR , et al. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. International Journal of Radiation Oncology, Biology, Physics1993;27(2):197‐206. ">Freeman 1993</a>); this observation was corroborated by other investigators who used hyperfractionated radiotherapy to 78 Gy (<a href="./references#CD010439-bbs2-0010" title="PackerR , BoyettJ , ZimmermanR , AlbrightA , KaplanA , RorkeL , et al. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy: a Children's Cancer Group phase I/II trial. Cancer1994;74(6):1827‐34. ">Packer 1994</a>; <a href="./references#CD010439-bbs2-0040" title="PradosMD ,  WaraWM ,  EdwardsMS ,  LarsonDA ,  LambornK ,  LevinVA . The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. International Journal of Radiation Oncology, Biology, Physics1995;32(1):85‐91. ">Prados 1995</a>). In hypofractionated regimens a total dose of 45 Gy is delivered in daily fractions of 3 to 5.5 Gy over three weeks (<a href="./references#CD010439-bbs2-0031" title="JanssensGO ,  GiddingCE ,  Van LindertEJ ,  OldenburgerFR ,  ErasmusCE ,  Schouten‐MeeterenAY ,  etal . The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study. International Journal of Radiation Oncology, Biology, Physics2009;73(3):722‐6. ">Janssens 2009</a>; <a href="./references#CD010439-bbs2-0007" title="NegrettiL , BouchirebK , Levy‐PiedboisC , HabrandJL , DhermainF , KalifaC . Hypofractionated radiotherapy in the treatment of diffuse intrinsic pontine glioma in children: a single institution's experience. Journal of Neuro‐Oncology2011;104(3):773‐7. ">Negretti 2011</a>). The advantages of hypofractionated radiotherapy include the shorter overall treatment time with a reduction in the associated economic burden, reduced supportive care, limited toxicity, and the same efficacy as conventionally fractionated radiotherapy. </p> <p>So far, there is no meta‐analysis or systematic review available that assesses the benefits or harms of radiation in people with DBG. This review aimed to evaluate the existing evidence on radiotherapy in treating children and young adults aged 0 to 21 years with newly diagnosed DBG. </p> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010439-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010439-sec-0017">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010439-sec-0100">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010439-sec-0017"></div> <p>To assess the effects of conventional fractionated radiotherapy (with or without chemotherapy) versus other therapies (including different radiotherapy techniques) for newly diagnosed diffuse brainstem gliomas in children and young adults aged 0 to 21 years. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010439-sec-0018" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010439-sec-0018">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010439-sec-0101">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010439-sec-0018"></div> <section id="CD010439-sec-0019"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010439-sec-0020"> <h4 class="title">Types of studies</h4> <p>We included all randomised controlled trials (RCTs) and quasi‐randomised trials (QRCTs) or controlled clinical trials (CCTs), as defined by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="http://www.archie.cochrane.org/sections/documents/view?document=63825953688192003220110331160213%26format=REVMAN#REF-Higgins-2011#REF-Higgins-2011" target="_blank">Higgins 2011</a>), that compared conventional fractionated radiotherapy (with or without chemotherapy) versus other therapies (including different radiotherapy techniques). We did not include uncontrolled observational trials. </p> </section> <section id="CD010439-sec-0021"> <h4 class="title">Types of participants</h4> <p>Participants met the following criteria:</p> <p> <ul id="CD010439-list-0001"> <li> <p>aged of 0 to 21 years at treatment;</p> </li> <li> <p>diagnosis of DBG made as described in the original studies;</p> </li> <li> <p>DBG was newly diagnosed and previously untreated with radiotherapy.</p> </li> </ul> </p> </section> <section id="CD010439-sec-0022"> <h4 class="title">Types of interventions</h4> <p>Conventional fractionated radiotherapy (with or without chemotherapy) versus other therapies (including different radiotherapy techniques). Trials differed only in respect of radiotherapy modalities. The deﬁnition of conventional radiotherapy was external‐beam radiotherapy and local field radiotherapy. </p> </section> <section id="CD010439-sec-0023"> <h4 class="title">Types of outcome measures</h4> <section id="CD010439-sec-0024"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010439-list-0002"> <li> <p>Overall survival (OS), defined as time from tumour diagnosis, or treatment, to death from any cause. </p> </li> </ul> </p> </section> <section id="CD010439-sec-0025"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010439-list-0003"> <li> <p>Progression‐free survival (PFS): progression defined clinically or radiologically (or both) as an increase of 25% or more in the size of the tumour on imaging, or as the appearance of a new lesion (or both). PFS defined as time from diagnosis, study entry, or treatment to progression. </p> </li> <li> <p>Event‐free survival (EFS): defined as time from diagnosis, study entry, or treatment to disease progression, disease relapse, a second malignant neoplasm, or death from any cause. </p> </li> <li> <p>Quality of life (QoL) (as defined by the trial authors).</p> </li> <li> <p>Neurological response: defined as the number of participants with improved neurological function. </p> </li> <li> <p>Radiological response: defined as the number of participants with a reduction in tumour size of more than 50% (<a href="./references#CD010439-bbs2-0023" title="GnekowAK . Recommendations of the Brain Tumor Subcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee. International Society of Pediatric Oncology. Medical and Pediatric Oncology1995;24(2):104‐8. ">Gnekow 1995</a>). </p> </li> <li> <p>Toxicity (as defined by the trial authors).</p> </li> </ul> </p> </section> </section> </section> <section id="CD010439-sec-0026"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010439-sec-0027"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases:</p> <p> <ul id="CD010439-list-0004"> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL) (2015, Issue 7);</p> </li> <li> <p>MEDLINE/PubMed (1945 to 19 August 2015);</p> </li> <li> <p>EMBASE/Ovid (1980 to 19 August 2015).</p> </li> </ul> </p> <p>The appendices show the search strategies for the different electronic databases (using a combination of controlled vocabulary and text words) (<a href="./appendices#CD010439-sec-0087">Appendix 1</a>; <a href="./appendices#CD010439-sec-0088">Appendix 2</a>; <a href="./appendices#CD010439-sec-0089">Appendix 3</a>). </p> </section> <section id="CD010439-sec-0028"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of relevant articles and review articles to identify potentially eligible citations. </p> <p>We scanned the following conference proceedings electronically, from 1 January 2010 to 19 August 2015 (<a href="./appendices#CD010439-sec-0090">Appendix 4</a>): </p> <p> <ul id="CD010439-list-0005"> <li> <p>International Society for Paediatric Oncology (SIOP);</p> </li> <li> <p>International Symposium on Paediatric Neuro‐Oncology (ISPNO);</p> </li> <li> <p>Society of Neuro‐Oncology (SNO);</p> </li> <li> <p>European Association of Neuro‐Oncology (EANO).</p> </li> </ul> </p> <p>We searched the following trials registers to 19 August 2015 (<a href="./appendices#CD010439-sec-0091">Appendix 5</a>): </p> <p> <ul id="CD010439-list-0006"> <li> <p>International Standard Randomised Controlled Trial Number (ISRCTN) Register (<a href="http://www.isrctn.com" target="_blank">www.isrctn.com</a>/); </p> </li> <li> <p>the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP, <a href="http://apps.who.int/trialsearch" target="_blank">apps.who.int/trialsearch</a>); </p> </li> <li> <p>the register of the National Institutes of Health (NIH) (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>) for ongoing trials. </p> </li> </ul> </p> <p>We did not impose any language restrictions and we will update the searches every two years. </p> </section> </section> <section id="CD010439-sec-0029"> <h3 class="title" id="CD010439-sec-0029">Data collection and analysis</h3> <section id="CD010439-sec-0030"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently screened the titles and abstracts of studies identified through the searches, and selected trials that possibly met the inclusion criteria. We retrieved full‐text articles for further assessment. We used discussion and consultation with a third review author to resolve any disagreements. </p> </section> <section id="CD010439-sec-0031"> <h4 class="title">Data extraction and management</h4> <p>For included studies, two review authors extracted the following information independently, using a standard form. </p> <section id="CD010439-sec-0032"> <h5 class="title">General information</h5> <p> <ul id="CD010439-list-0007"> <li> <p>Title.</p> </li> <li> <p>Authors.</p> </li> <li> <p>Whether trial was published or unpublished.</p> </li> <li> <p>Year of publication.</p> </li> <li> <p>Language of publication.</p> </li> <li> <p>Duplicate publications.</p> </li> <li> <p>Study design.</p> </li> <li> <p>Country.</p> </li> <li> <p>Reference/source.</p> </li> <li> <p>Contact address.</p> </li> <li> <p>Sponsor(s).</p> </li> <li> <p>Setting.</p> </li> <li> <p>Funding.</p> </li> <li> <p>Declaration of interest.</p> </li> </ul> </p> </section> <section id="CD010439-sec-0033"> <h5 class="title">Intervention</h5> <p> <ul id="CD010439-list-0008"> <li> <p>Radiation techniques.</p> </li> <li> <p>Dose.</p> </li> <li> <p>Duration.</p> </li> <li> <p>Control intervention.</p> </li> <li> <p>Concomitant therapy and timing.</p> </li> </ul> </p> </section> <section id="CD010439-sec-0034"> <h5 class="title">Participants</h5> <p> <ul id="CD010439-list-0009"> <li> <p>Sampling.</p> </li> <li> <p>Total number and number in comparison groups.</p> </li> <li> <p>Sex.</p> </li> <li> <p>Age.</p> </li> <li> <p>Trial inclusion and exclusion criteria.</p> </li> <li> <p>Withdrawals and losses to follow‐up (with reasons and descriptions).</p> </li> <li> <p>Subgroups.</p> </li> </ul> </p> </section> <section id="CD010439-sec-0035"> <h5 class="title">Outcomes</h5> <p> <ul id="CD010439-list-0010"> <li> <p>Outcomes specified above that are included in the trial report(s).</p> </li> <li> <p>Length of follow‐up.</p> </li> <li> <p>Quality of reporting of outcomes.</p> </li> </ul> </p> <p>If there were differences in data extraction, we resolved them by discussion, referring back to the original paper, or by consultation with a third review author. In addition, we contacted authors about information missing from their trial reports, if necessary. </p> </section> </section> <section id="CD010439-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors assessed the methodological quality of included RCTs, QRCTs, and CCTs using the Cochrane 'Risk of bias' tool (<a href="./references#CD010439-bbs2-0027" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). The tool considered six domains of bias: sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting, and other issues. For each domain, the study method was described using verbatim quotes (i.e. quotations from the original paper(s)) and judged for adequacy ('Yes' (adequate), 'No' (inadequate), 'Unclear' (insufficient information to decide 'Yes' or 'No')). A judgement of 'Yes' indicated low risk of bias, while 'No' indicated high risk of bias. We added items for the assessment of risk of bias as described in the module of the Cochrane Childhood Cancer Group (<a href="./references#CD010439-bbs2-0034" title="KremerLCM , LeclercqE , van Dalen EC. Cochrane Childhood Cancer Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2014, Issue 3.Art. No.: CHILDCA.. ">Kremer 2014</a>). We resolved any disagreements by discussion, or by using a third‐party arbitrator, and presented the results in the 'Risk of bias' table, and in both graphical and written summary form. </p> </section> <section id="CD010439-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>For time‐to‐event data (e.g. OS, EFS and PFS), we used hazard ratios (HR) with 95% confidence intervals (CI). If HRs were not explicitly presented in the study, we used Parmar's method (<a href="./references#CD010439-bbs2-0038" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine1998;17(24):2815‐34. ">Parmar 1998</a>). </p> <p>For dichotomous outcomes (e.g. radiological and neurological response to treatment, toxicities), we calculated risk ratios (RR) with 95% CI for each trial. </p> <p>For continuous outcomes (e.g. QoL), we evaluated mean difference (MD) or standardised mean difference (SMD) with 95% CI. We used the MD between the treatment arms at the end of follow‐ up if all trials measured the outcome on the same scale, otherwise, we used the SMD. </p> </section> <section id="CD010439-sec-0038"> <h4 class="title">Dealing with missing data</h4> <p>During our review, we tried to contact authors of both included studies to clarify or gather missing data with regard to our study selection, risk of bias assessment, and data extraction. We successfully contacted Dr. Peter C. Adamson, chair of the Children's Oncology Group, and the corresponding author of <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> for additional information. If appropriate, we performed intention‐to‐treat analyses. </p> </section> <section id="CD010439-sec-0039"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to assess heterogeneity both by visual inspection of the forest plots and by a formal statistical test for heterogeneity, the I<sup>2</sup> statistic. In the absence of significant heterogeneity (I<sup>2</sup> less than 50%) (<a href="http://archie.cochrane.org/sections/documents/view?version=z1407011355590214383520337112314%26format=REVMAN#REF-Higgins-2011" target="_blank">Higgins 2011</a>), we planned to use a fixed‐effect model for the estimation of treatment effects. Otherwise, we intended to explore possible reasons for the occurrence of heterogeneity and take appropriate measures, such as using a random‐effects model. However, assessment of heterogeneity was not applicable since, for each comparison, only one study was available. </p> </section> <section id="CD010439-sec-0040"> <h4 class="title">Assessment of reporting biases</h4> <p>We evaluated reporting bias as described in the 'Assessment of risk of bias' section. We planned to construct a funnel plot for reporting bias evaluation when there were a sufficient number of included studies (i.e. at least 10 studies included in a meta‐analysis) because otherwise the power of the test is too low to distinguish chance from real asymmetry (<a href="http://archie.cochrane.org/sections/documents/view?version=z1407011355590214383520337112314%26format=REVMAN#REF-Higgins-2011" target="_blank">Higgins 2011</a>). Since pooling of results was not possible, this was not applicable. </p> </section> <section id="CD010439-sec-0041"> <h4 class="title">Data synthesis</h4> <p>We carried out data synthesis and analyses using Review Manager 5 (<a href="./references#CD010439-bbs2-0041" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 2011</a>). For time‐to‐event data, we used the generic inverse variance function of Review Manager 5 to combine logs of the HRs. We used Pamar's method to obtain the necessary data (<a href="./references#CD010439-bbs2-0038" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine1998;17(24):2815‐34. ">Parmar 1998</a>). Dichotomous outcomes were related to risk using the RR. We used the fixed‐effect model throughout the review. Since the two included studies tested different comparisons, pooling of results was not possible. </p> <p>For each comparison, we prepared a 'Summary of findings' table using the GRADE profiler software, in which we presented the following outcomes: OS, EFS, PFS, QoL, neurological response, radiological response, and toxicities. Two review authors independently assessed the quality of the evidence using the five GRADE considerations, that is, study limitations, inconsistency, indirectness, imprecision, and publication bias. </p> </section> <section id="CD010439-sec-0042"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If possible, we planned to carry out the following subgroup analyses:</p> <p> <ul id="CD010439-list-0011"> <li> <p>age at onset of radiotherapy (less than three years old versus three years old or older); </p> </li> <li> <p>different radiation techniques;</p> </li> <li> <p>different concomitant therapies.</p> </li> </ul> </p> </section> <section id="CD010439-sec-0043"> <h4 class="title">Sensitivity analysis</h4> <p>Since for each comparison we found only one study, sensitivity analyses were not applicable.</p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010439-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010439-sec-0044"></div> <section id="CD010439-sec-0045"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD010439-sec-0096" title="">Characteristics of included studies</a>; <a href="./references#CD010439-sec-0097" title="">Characteristics of excluded studies</a>; <a href="./references#CD010439-sec-0098" title="">Characteristics of ongoing studies</a> tables. </p> <section id="CD010439-sec-0046"> <h4 class="title">Results of the search</h4> <p>The initial search identified 3414 records, 112 from CENTRAL, 771 from MEDLINE/PubMed, 2180 from EMBASE, 71 from trials registers (45 from the NIH register; 10 from the WHO register; 16 from the ISRCTN register), 279 from conference abstracts (69 from SIOP, 128 from ISPNO, 62 from SNO, and 20 from EANO), and 1 identified by screening reference lists (<a href="./references#CD010439-bbs2-0005" title="JanssensGO , JansenMH , LauwersSJ , NowakPJ , OldenburgerFR , BouffetE , et al. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched‐cohort analysis. International Journal of Radiation Oncology, Biology, Physics2013;85(2):315‐20. ">Janssens 2013</a>). <a href="#CD010439-fig-0001">Figure 1</a> shows the process of study selection. After excluding 379 duplicating records, we screened the titles and abstracts of the remaining 3035 records. We subsequently excluded another 3022 records as they did not meet the inclusion criteria. We obtained the full‐text publications of the remaining 13 studies (including one conference abstract and one ongoing trial) and read them thoroughly to assess eligibility. Finally, we considered two studies (<a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a>; <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>) and one ongoing trial (<a href="./references#CD010439-bbs2-0013" title="NCT01878266 . Prospective randomized trial of two hypofractionated radiotherapy regimens versus conventional radiotherapy in pediatric diffuse brainstem glioma. www.clinicaltrials.gov/ct2/show/study/NCT01878266 (accessed 4 April 2016). ">NCT01878266</a>) eligible in this review. </p> <div class="figure" id="CD010439-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010439-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010439-sec-0047"> <h4 class="title">Included studies</h4> <p>See: <a href="./references#CD010439-sec-0096" title="">Characteristics of included studies</a> table. </p> <p>Only two trials were eligible for inclusion, both of which were RCT design (<a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a>; <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>). </p> <p>The <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> trial was a multi‐institutional phase III RCT. This study focused on the comparison between conventional radiotherapy versus hyperfractionated radiotherapy. A total of 132 children and young adults were enrolled between June 1992 and March 1996. Two participants were considered ineligible due to an error in diagnosis. Diagnosis of diffuse brainstem tumour was based on clinical and radiological findings. Histological diagnosis was established in 22 participants, 10 in the conventional radiotherapy group and 12 in the hyperfractionated radiotherapy group. Median age was 78 months in the conventional radiotherapy group, and 74 months in the hyperfractionated radiotherapy group. The treatment was initiated within 28 days of diagnosis, consisting of a six‐week course of local field radiotherapy with either conventional regimen or hyperfractionated regimen (details in <a href="./references#CD010439-sec-0096" title="">Characteristics of included studies</a> table). Cisplatin was added as a potential radiosensitiser in all participants. All participants received steroid medication during radiotherapy. Participants were followed until death or October 1997, and five were lost to follow‐up. </p> <p>The second RCT included 71 eligible participants from July 2007 to July 2011 in Children's Cancer Hospital, Egypt (CCHE) (<a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>). Diagnosis of diffuse brainstem tumour was based on clinical and radiological findings. Participants were randomised to receive hypofractionated radiotherapy or conventional radiotherapy. Mean (± standard deviation (SD)) age was 8.3 ± 3.8 years in the hypofractionated radiotherapy group and 7.5 ± 4.1 years in the conventional radiotherapy group. Treatment was initiated within two weeks of diagnosis. Hypofractionated radiotherapy was delivered over 2.6 weeks to a total dose of 39 Gy. Conventional radiotherapy was delivered over six weeks to a total dose of 54 Gy (details in <a href="./references#CD010439-sec-0096" title="">Characteristics of included studies</a> table). No chemotherapy was administered during or after radiation. The dose of steroids was reduced in a tapering way identically in the two groups. The median follow‐up period was 9.0 months (range 1.3 to 25 months). Only one participant in the conventional radiotherapy group was lost to follow‐up. We contacted the corresponding author of this trial and were informed about exclusion criteria, funding, and conflicts of interest. </p> </section> <section id="CD010439-sec-0048"> <h4 class="title">Excluded studies</h4> <p>See: <a href="./references#CD010439-sec-0097" title="">Characteristics of excluded studies</a> table. </p> <p>We excluded 10 studies: two studies were retrospective design (<a href="./references#CD010439-bbs2-0007" title="NegrettiL , BouchirebK , Levy‐PiedboisC , HabrandJL , DhermainF , KalifaC . Hypofractionated radiotherapy in the treatment of diffuse intrinsic pontine glioma in children: a single institution's experience. Journal of Neuro‐Oncology2011;104(3):773‐7. ">Negretti 2011</a>; <a href="./references#CD010439-bbs2-0012" title="SunT , WanW , WuZ , ZhangJ , ZhangL . Clinical outcomes and natural history of pediatric brainstem tumors: With 33 cases follow‐ups. Neurosurgical Review2013;36(2):311‐9. ">Sun 2013</a>), five were cohort studies (<a href="./references#CD010439-bbs2-0008" title="PackerRJ , AllenJC , GoldweinJL , NewallJ , ZimmermanRA , PriestJ , et al. Hyperfractionated radiotherapy for children with brainstem gliomas: a pilot study using 7,200 cGy. Annals of Neurology1990;27(2):167‐73. ">Packer 1990</a>; <a href="./references#CD010439-bbs2-0004" title="FreemanCR , KrischerJP , SanfordRA , CohenME , BurgerPC , delCarpioR , et al. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. International Journal of Radiation Oncology, Biology, Physics1993;27(2):197‐206. ">Freeman 1993</a>; <a href="./references#CD010439-bbs2-0006" title="KretschmarCS , TarbellNJ , BarnesPD , KrischerJP , BurgerPC , KunL . Pre‐irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the pediatric oncology group, protocol 8833. Cancer1993;72(4):1404‐13. ">Kretschmar 1993</a>; <a href="./references#CD010439-bbs2-0009" title="PackerRJ , BoyettJM , ZimmermanRA , RorkeLB , KaplanAM , AlbrightAL , et al. Hyperfractionated radiation therapy (72 gy) for children with brain stem gliomas. A Children's Cancer Group phase I/II trial. Cancer1993;72(4):1414‐21. ">Packer 1993</a>; <a href="./references#CD010439-bbs2-0010" title="PackerR , BoyettJ , ZimmermanR , AlbrightA , KaplanA , RorkeL , et al. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy: a Children's Cancer Group phase I/II trial. Cancer1994;74(6):1827‐34. ">Packer 1994</a>), one was matched‐cohort analysis (<a href="./references#CD010439-bbs2-0005" title="JanssensGO , JansenMH , LauwersSJ , NowakPJ , OldenburgerFR , BouffetE , et al. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched‐cohort analysis. International Journal of Radiation Oncology, Biology, Physics2013;85(2):315‐20. ">Janssens 2013</a>), one was a comment letter (<a href="./references#CD010439-bbs2-0011" title="RoosDE , SmithJG . Randomized trial on radiotherapy for paediatric diffuse intrinsic pontine glioma (DIPG). Radiotherapy and Oncology2014;113(3):425. ">Roos 2014</a>), and one was a conference abstract (<a href="./references#CD010439-bbs2-0003" title="AhmedS , ZaghloulMS , EldebawyE . Hypofractionated radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG) [O128]. Pediatric Blood and Cancer2012;59(6):1003. ">Ahmed 2012</a>) that was reported in full‐text (<a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>). </p> <section id="CD010439-sec-0049"> <h5 class="title">Ongoing studies</h5> <p>See: <a href="./references#CD010439-sec-0098" title="">Characteristics of ongoing studies</a> table. </p> <p>One RCT is ongoing comparing two hypofractionated radiotherapy regimens versus conventional radiotherapy in children with newly diagnosed DIPG. </p> </section> </section> </section> <section id="CD010439-sec-0050"> <h3 class="title">Risk of bias in included studies</h3> <p><a href="#CD010439-fig-0002">Figure 2</a> shows the risk of bias on seven items for each included trial. The 'Risk of bias' table details judgement of bias (see <a href="./references#CD010439-sec-0096" title="">Characteristics of included studies</a> table). We contacted Dr. Peter C. Adamson, chair of the Children's Oncology Group, who provided the study protocol of <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a>. We contacted the corresponding author of <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>, who provided information about random sequence generation, allocation concealment, blinding of outcome assessment, incomplete outcome data, follow‐up time, and median age. </p> <div class="figure" id="CD010439-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010439-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010439-sec-0051"> <h4 class="title">Allocation</h4> <p>For evaluating selection bias, we assessed random sequence generation and allocation concealment. The risk was unclear in <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> and low in <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>. </p> </section> <section id="CD010439-sec-0052"> <h4 class="title">Blinding</h4> <p>For evaluating performance bias, we assessed the blinding of participants and personnel. Although neither of the studies clearly stated whether blinding was done, it was impossible to blind the participants or personnel, considering the different nature of the intervention (conventional: daily for 30 fractions; hyperfractionated: twice a day for 60 fractions; hypofractionated: daily for 13 fractions), Thus, we considered both trials to have a high risk of performance bias. </p> <p>For evaluating detection bias, we assessed the blinding of outcome assessors for each separate outcome. For OS, we considered both <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> and <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> to have a low risk of detection bias since this outcome was unlikely to be affected by assessors' knowledge of the assignment status. <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> also reported radiological response and toxicities: risk of detection bias for these outcomes was unclear. <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> also reported toxicities: risk of detection bias for these outcomes was high. </p> </section> <section id="CD010439-sec-0053"> <h4 class="title">Incomplete outcome data</h4> <p>For evaluating attrition bias, we assessed incomplete outcome data for each separate outcome. Both studies reported OS: the risk of attrition bias was low. Both studies reported toxicities: the risk of attrition bias was high in <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> and low in <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>. <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> reported radiological response: the risk of attrition bias was high. </p> </section> <section id="CD010439-sec-0054"> <h4 class="title">Selective reporting</h4> <p>For evaluating reporting bias, we assessed selective reporting. The risk of bias was unclear for <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> and low for <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>. </p> </section> <section id="CD010439-sec-0055"> <h4 class="title">Other potential sources of bias</h4> <p>For evaluating other potential sources of bias, we assessed the following items: block randomisation in unblinded trials, baseline imbalance between treatment groups related to outcome (prior chemotherapy and radiotherapy, age, sex), and difference in length of follow‐up between treatment arms. The risk was unclear for <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a>. <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> did not conduct block randomisation; baseline characteristics were balanced; and there was no significant difference in length of follow‐up between treatment groups. Taken together, we considered there was low risk of other bias for <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>, </p> </section> </section> <section id="CD010439-sec-0056"> <h3 class="title" id="CD010439-sec-0056">Effects of interventions</h3> <p>See: <a href="./full#CD010439-tbl-0001"><b>Summary of findings for the main comparison</b> Hyperfractionated radiotherapy compared with conventional radiotherapy for diffuse brainstem glioma in children and young adults</a>; <a href="./full#CD010439-tbl-0002"><b>Summary of findings 2</b> Hypofractionated radiotherapy compared with conventional radiotherapy for diffuse brainstem glioma in children and young adults</a> </p> <p>See: <a href="./full#CD010439-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD010439-tbl-0002">summary of findings Table 2</a>. </p> <p>We did not combine the data of these two RCTs using meta‐analysis since they reported different comparisons. Instead, we presented results for each trial separately. </p> <section id="CD010439-sec-0057"> <h4 class="title">Comparison 1: hyperfractionated radiotherapy versus conventional radiotherapy</h4> <p>Only one RCT compared hyperfractionated radiotherapy versus conventional radiotherapy (<a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a>). </p> <section id="CD010439-sec-0058"> <h5 class="title">Overall survival</h5> <p>The analysis included all 130 participants (66 for conventional radiotherapy and 64 for hyperfractionated radiotherapy). <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> reported that the median time to death was 8.5 months (range 3 to 24 months) for participants receiving conventional radiotherapy, and 8 months (range 1 to 23 months) for participants receiving hyperfractionated radiotherapy. We detected no significant difference in OS between the groups (one study, 130 participants, HR 1.07, 95% CI 0.75 to 1.53, P value = 0.70; <a href="#CD010439-fig-0003">Figure 3</a>; <a href="./references#CD010439-fig-0010" title="">Analysis 1.1</a>). </p> <div class="figure" id="CD010439-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.1 Overall survival." data-id="CD010439-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.1 Overall survival. </p> </div> </div> </div> </section> <section id="CD010439-sec-0059"> <h5 class="title">Progression‐free survival</h5> <p>The <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> trial did not assess PFS. </p> </section> <section id="CD010439-sec-0060"> <h5 class="title">Event‐free survival</h5> <p>The analysis included all 130 participants (66 for conventional radiotherapy and 64 for hyperfractionated radiotherapy). <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> reported that the median EFS was six months (range 2 to 15 months) for participants receiving conventional radiotherapy, and five months (range 1 to 12 months) for participants receiving hyperfractionated radiotherapy. We detected no significant difference in EFS between the participants who received hyperfractionated radiotherapy and participants who received conventional radiotherapy (one study, 130 participants, HR 1.26, 95% CI 0.83 to 1.90, P value = 0.27; <a href="#CD010439-fig-0004">Figure 4</a>; <a href="./references#CD010439-fig-0011" title="">Analysis 1.2</a>). </p> <div class="figure" id="CD010439-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.2 Event‐free survival." data-id="CD010439-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.2 Event‐free survival. </p> </div> </div> </div> </section> <section id="CD010439-sec-0061"> <h5 class="title">Quality of life</h5> <p>The <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> trial did not assess QoL. </p> </section> <section id="CD010439-sec-0062"> <h5 class="title">Neurological response</h5> <p><a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> reported the neurological response for the whole group of participants rather than for treatment groups. Thus, we could not calculate RR for corresponding neurological response. </p> </section> <section id="CD010439-sec-0063"> <h5 class="title">Radiological response</h5> <p>Only 108/130 participants (57 in the conventional radiotherapy group and 51 in the hyperfractionated radiotherapy group) in <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> were available for review of post‐treatment MRI. For the conventional radiotherapy group, the authors reported that there was complete response in one participant, partial response (greater than 50% decrease in size) in 18 participants, stable response in 25 participants, and progressive response (increase in size of disease on MRI) in 13 participants. For the hyperfractionated radiotherapy group, the authors observed complete response in one participant, partial response in 15 participants, stable response in 23 participants, and progressive response in 12 participants. There is no evidence of difference in radiological response between the two groups (RR 0.94, 95% CI 0.54 to 1.63, P value = 0.83; <a href="#CD010439-fig-0005">Figure 5</a>; <a href="./references#CD010439-fig-0012" title="">Analysis 1.3</a>). </p> <div class="figure" id="CD010439-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.3 Radiological response." data-id="CD010439-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.3 Radiological response. </p> </div> </div> </div> </section> <section id="CD010439-sec-0064"> <h5 class="title">Toxicities</h5> <p><a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> presented various types of toxicities, most of which were both recorded in both the conventional radiotherapy group (58 participants, unless otherwise stated (NOS)) and hyperfractionated radiotherapy group (55 participants). This trial graded the toxicities into six categories (i.e. 1 to 5 and unknown (UNK)). All the observed toxicities were minimal to mild. There was no grade 4 or 5 toxicity of hearing loss or renal dysfunction. Given the fact that the distribution of each reported toxicity in both groups was similar, we combined the count in each grade for specific toxicity item, with the aim of transferring it to dichotomous variable (i.e. toxicity and non‐toxicity). There was no evidence of difference between the hyperfractionated radiotherapy group and the conventional radiotherapy group with regards to platelets (RR 1.58, 95% CI 0.27 to 9.11, P value = 0.61), haemoglobin (RR 3.16, 95% CI 0.34 to 29.51, P value = 0.31), infection NOS/UNK (RR 1.05, 95% CI 0.22 to 5.00, P value = 0.95), sepsis and bacteria (RR 2.11, 95% CI 0.20 to 22.61, P value = 0.54), upper respiratory infection/otitis (RR 1.05, 95% CI 0.43 to 2.61, P value = 0.91), abscess (RR 2.11, 95% CI 0.20 to 22.61, P value = 0.54), other bacterial (RR 1.05, 95% CI 0.15 to 7.23, P value = 0.96), fungal NOS/UNK (RR 0.35, 95% CI 0.04 to 3.28, P value = 0.36), fungal stomatitis (RR 1.24, 95% CI 0.40 to 3.84, P value = 0.70; 57 participants in the conventional radiotherapy group), alopecia (RR 1.76, 95% CI 0.44 to 7.01, P value = 0.42), decrease of magnesium (electrolyte imbalance) (RR 0.41, 95% CI 0.15 to 1.06, P value = 0.07), decrease of sodium (electrolyte imbalance) (RR 2.11, 95% CI 0.20 to 22.61, P value = 0.54), hearing (subjective) (RR 2.11, 95% CI 0.20 to 22.61, P value = 0.54), and hearing (objective) (RR 1.51, 95% CI 0.62 to 3.68, P value = 0.37) (see: <a href="#CD010439-fig-0006">Figure 6</a>; <a href="./references#CD010439-fig-0013" title="">Analysis 1.4</a>). </p> <div class="figure" id="CD010439-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.4 Toxicities." data-id="CD010439-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.4 Toxicities. </p> </div> </div> </div> </section> <section id="CD010439-sec-0065"> <h5 class="title">Subgroup analysis</h5> <p>We did not perform a subgroup analysis due to lack of data from the included study.</p> </section> </section> <section id="CD010439-sec-0066"> <h4 class="title">Comparison 2: hypofractionated radiotherapy versus conventional radiotherapy</h4> <p>Only one RCT compared hypofractionated radiotherapy versus conventional radiotherapy (<a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>). In this trial, one participant in the conventional radiotherapy was lost to follow‐up. The corresponding author from <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> stated that the participant lost for follow‐up was enrolled in OS and adverse effects with the last observation carried forward (not as best or worst case). </p> <section id="CD010439-sec-0067"> <h5 class="title">Overall survival</h5> <p>The analysis included 71 participants (36 in the conventional radiotherapy group and 35 in the hypofractionated radiotherapy group). For the hypofractionated radiotherapy group, <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> reported a median OS of 7.8 months. For the conventional radiotherapy group, <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> reported a median OS of 9.5 months. There was no significant difference between the groups (one study, 71 participants, HR 1.03, 95% CI 0.53 to 2.01, P value = 0.93; <a href="#CD010439-fig-0007">Figure 7</a>; <a href="./references#CD010439-fig-0014" title="">Analysis 2.1</a>). </p> <div class="figure" id="CD010439-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Hypofractionated radiotherapy versus conventional radiotherapy, outcome: 2.1 Overall survival." data-id="CD010439-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Hypofractionated radiotherapy versus conventional radiotherapy, outcome: 2.1 Overall survival. </p> </div> </div> </div> </section> <section id="CD010439-sec-0068"> <h5 class="title">Progression‐free survival</h5> <p>The analysis included 71 participants (36 in the conventional radiotherapy group and 35 in the hypofractionated radiotherapy group). For the hypofractionated radiotherapy group, <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> reported a median PFS of 6.3 months (range 3.7 to 8.8 months). For the conventional radiotherapy group, <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> reported a median PFS of 7.3 months (range 5.5 to 9.2 months). There was no significant difference between groups (one study, 71 participants, HR 1.19, 95% CI 0.63 to 2.22, P value = 0.60; <a href="#CD010439-fig-0008">Figure 8</a>; <a href="./references#CD010439-fig-0015" title="">Analysis 2.2</a>). </p> <div class="figure" id="CD010439-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Hypofractionated radiotherapy versus conventional radiotherapy, outcome: 2.2 Progression‐free survival." data-id="CD010439-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Hypofractionated radiotherapy versus conventional radiotherapy, outcome: 2.2 Progression‐free survival. </p> </div> </div> </div> </section> <section id="CD010439-sec-0069"> <h5 class="title">Event‐free survival</h5> <p>The <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> trial did not assess EFS. </p> </section> <section id="CD010439-sec-0070"> <h5 class="title">Quality of life</h5> <p>The <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> trial did not assess QoL </p> </section> <section id="CD010439-sec-0071"> <h5 class="title">Neurological response</h5> <p>The <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> trial did not assess neurological response. </p> </section> <section id="CD010439-sec-0072"> <h5 class="title">Radiological response</h5> <p>The <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> trial did not assess radiological response. </p> </section> <section id="CD010439-sec-0073"> <h5 class="title">Toxicities</h5> <p>The trial reported information on adverse effects for all included participants. The most frequent adverse effect was local erythema and dry desquamation, especially behind the auricles, with 16 participants in the hyperfractionated radiotherapy group and 17 participants in conventional radiotherapy group. The difference was not significant (RR 0.97, 95% CI 0.59 to 1.60, P value = 0.90). For other less frequent adverse effects, there were no differences in hearing (RR 1.54, 95% CI 0.27 to 8.68, P value = 0.62), decreased appetite (RR 1.54, 95% CI 0.27 to 8.68, P value = 0.62), dysphagia (RR 1.37, 95% CI 0.33 to 5.69, P value = 0.66), fatigue (RR 1.10, 95% CI 0.63 to 1.93, P value = 0.73), insomnia (RR 0.69, 95% CI 0.12 to 3.86, P value = 0.67), night mares (RR 1.03, 95% CI 0.15 to 6.90, P value = 0.98), or seizures (RR 0.34, 95% CI 0.01 to 8.14, P value = 0.51) (see: <a href="#CD010439-fig-0009">Figure 9</a>; <a href="./references#CD010439-fig-0016" title="">Analysis 2.3</a>). </p> <div class="figure" id="CD010439-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Hypofractionated radiotherapy versus conventional radiotherapy, outcome: 2.3 Toxicities." data-id="CD010439-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Hypofractionated radiotherapy versus conventional radiotherapy, outcome: 2.3 Toxicities. </p> </div> </div> </div> </section> <section id="CD010439-sec-0074"> <h5 class="title">Subgroup analysis</h5> <p>We did not perform a subgroup analysis due to lack of data from the included study.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010439-sec-0075" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010439-sec-0075">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010439-sec-0109">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010439-sec-0075"></div> <section id="CD010439-sec-0076"> <h3 class="title" id="CD010439-sec-0076">Summary of main results</h3> <p>This systematic review included two RCTs that investigated the benefits and harms of two different radiotherapy techniques (compared with conventional radiotherapy) in children and young adults aged 0 to 21 years with newly diagnosed DBG. <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a>, a multi‐institutional RCT, enrolled 130 participants and compared hyperfractionated radiotherapy with conventional radiotherapy. We detected no clear evidence of effect on OS or EFS in participants received hyperfractionated radiotherapy when compared with participants received conventional radiotherapy. Radiological response and various types of toxicities were similar between the two groups. There were no severe toxicities. The second trial included 71 participants and compared hypofractionated radiotherapy with conventional radiotherapy (<a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>). Based on this trial, we found no clear evidence of effect on OS or PFS in participants who received hypofractionated radiotherapy compared with participants who received conventional radiotherapy. The main adverse effect was local erythema and dry desquamation, especially behind the auricles, with a similar proportion in the two groups. There were other toxicities, but there was no statistically significant different between the treatment groups. </p> </section> <section id="CD010439-sec-0077"> <h3 class="title" id="CD010439-sec-0077">Overall completeness and applicability of evidence</h3> <p>We attempted to identify all relevant studies. We are confident that majority of published trials are included in this review. In both included RCTs, the diagnosis of DBG was established based on MRI findings (in <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a>, at least two‐thirds of the diffuse lesion was intrinsic to the pons; in <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>, diffuse infiltration of more than 50% of the pons with or without extension to the midbrain or medulla oblongata (or both)) and clinical findings (at least two of the three typical brainstem symptoms, cranial nerve deficit, long tract signs, and ataxia). However, in our protocol, we also specified the T1 and T2 findings from MRI as one of the diagnostic criteria, which were actually unavailable in both included studies. Therefore, we modified the diagnostic criteria as 'Diagnosis of DBG made as described in the original studies'. EFS, focusing on time to disease progression, disease relapse, a second malignant neoplasm, or death from any cause, could also provide valuable information regarding the treatment outcome. Therefore, it was included in this review although we did not include it as secondary outcome in prior protocol. Both included studies reported the primary outcome. For the secondary outcomes, only toxicity was reported in both included studies; only <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> reported EFS and radiological response; only <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> reported PFS. Neither study included QoL and neurological response. It should be noted that <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> provided information about neurological response for all available participants rather than per treatment group; they reported that all participants received steroid medication during radiotherapy but presented no more details. Instead of taking the neurological symptoms as a whole, <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> compared each symptom along the course of therapy between the hypofractionated radiotherapy group and the conventional radiotherapy group. They reported a non‐significant trend towards more rapid improvement in cranial nerve palsy by the hyperfractionated radiotherapy group. </p> <p>It is noteworthy that <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> recommended conventional rather than hyperfractionated radiotherapy as the radiotherapeutic regimen of choice due to the similar outcome and there being less treatment burden for the participant and family as well as the radiation oncology department. Furthermore, one participant in the hyperfractionated radiotherapy group in this study was histologically diagnosed as hemangioblastoma, which is not a diagnosis of interest for this review and which might have a more favourable prognosis. Moreover, only 22 of the 130 participants had a histological diagnosis. Therefore, it is possible that there are more ineligible participants included. These confounding factors could influence the applicability of its results to current clinical practice. However, some studies shifted their aim to decrease the treatment burden and increase the quality of remaining life (<a href="./references#CD010439-bbs2-0031" title="JanssensGO ,  GiddingCE ,  Van LindertEJ ,  OldenburgerFR ,  ErasmusCE ,  Schouten‐MeeterenAY ,  etal . The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study. International Journal of Radiation Oncology, Biology, Physics2009;73(3):722‐6. ">Janssens 2009</a>; <a href="./references#CD010439-bbs2-0007" title="NegrettiL , BouchirebK , Levy‐PiedboisC , HabrandJL , DhermainF , KalifaC . Hypofractionated radiotherapy in the treatment of diffuse intrinsic pontine glioma in children: a single institution's experience. Journal of Neuro‐Oncology2011;104(3):773‐7. ">Negretti 2011</a>; <a href="./references#CD010439-bbs2-0005" title="JanssensGO , JansenMH , LauwersSJ , NowakPJ , OldenburgerFR , BouffetE , et al. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched‐cohort analysis. International Journal of Radiation Oncology, Biology, Physics2013;85(2):315‐20. ">Janssens 2013</a>; <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>). Effect of hypofractionated radiotherapy for DIPG was thus examined. </p> <p>Since only two RCTs were eligible and only one RCT was included for each specific comparison with limited sample size, combined with the limitation mentioned above, we could not draw conclusions or make any recommendations. It should also be noted that 'no evidence of effect', as identified in this review, is not the same as 'evidence of no effect'. </p> </section> <section id="CD010439-sec-0078"> <h3 class="title" id="CD010439-sec-0078">Quality of the evidence</h3> <p>We used the GRADE approach to assess the quality of evidence, and our judgements are presented in <a href="./full#CD010439-tbl-0001">summary of findings Table for the main comparison</a> and <a href="./full#CD010439-tbl-0002">summary of findings Table 2</a>. </p> <p>For the hyperfractionated radiotherapy versus conventional radiotherapy comparison, we included only one multi‐institutional RCT. This trial was well organised. Although the risk of bias was high for blinding of participants and personnel, it was acceptable since these two treatment modalities are very different from each other. The quality of evidence was low for OS and EFS, and very low for radiological response and toxicities. The main reason for downgrading was that only one trial with a small sample size was eligible. The sample size in <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> (130 participants) was estimated based on the assumption that there could be 80% power (one sided, P value = 0.05) to detect a 15% improvement in two‐year survival in hyperfractionated radiotherapy over the 15% expected on the conventional radiotherapy. In addition, the process of randomisation sequence generation and allocation concealment was not described. Furthermore, for the outcomes radiological response and toxicities, the incomplete outcome data also contributed to downgrading. </p> <p>For the hypofractionated radiotherapy versus conventional radiotherapy comparison, we included only one RCT. This trial was well organised, with protocol available, sample size estimation performed, and allocation concealed. The risk of bias was high for blinding of participants and personnel, but was reasonable since these two treatment modalities are very different from each other. The quality of evidence was moderate for OS and low for PFS and toxicities. The quality was downgraded mainly because only one trial with a small sample size was found for this comparison. In <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>, the sample size estimation was based on non‐inferiority test. However, it should be noted that the small sample size (only 71 children were included) might generate wider CI values. Furthermore, for PFS and toxicities, the presence of high risk of detection bias also contribute to the consideration of downgrading. </p> </section> <section id="CD010439-sec-0079"> <h3 class="title" id="CD010439-sec-0079">Potential biases in the review process</h3> <p>We followed a well‐designed search strategy to identify potentially eligible studies, with no restriction on language, publication status, or sample size. Two review authors independently conducted the study selection and data extraction processes. Therefore, we made every attempt to minimise bias during the review process. </p> </section> <section id="CD010439-sec-0080"> <h3 class="title" id="CD010439-sec-0080">Agreements and disagreements with other studies or reviews</h3> <p>Both RCTs used well‐specified eligibility criteria: at least two of the three typical brainstem symptoms with a clinical history of symptoms less than six months for <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> and no longer than three months for <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>; extent of pontine involvement of tumour on MRI was required (greater than 66% for <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a> and 50% or greater for <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>). Median age and age range in both studies were in agreement with many other clinical trials according to previous critical reviews (<a href="./references#CD010439-bbs2-0024" title="HargraveD ,  BartelsU ,  BouffetE . Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncology2006;7(3):241‐8. ">Hargrave 2006</a>; <a href="./references#CD010439-bbs2-0030" title="JansenMH , vanVuurdenDG , VandertopWP , KaspersGJ . Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treatment Reviews2012;38(1):27‐35. ">Jansen 2012</a>). In addition, according to the reported baseline characteristics, neither study included children younger than three years. For <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>, a Karnofsky/Lansky play status of 50% or greater was required. For <a href="./references#CD010439-bbs2-0001" title="MandellLR , KadotaR , FreemanC , DouglassEC , FontanesiJ , CohenME , et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy. International Journal of Radiation Oncology, Biology, Physics1999;43(5):959‐64. ">Mandell 1999</a>, median OS in the hyperfractionated radiotherapy group (8.0 months) was within the range (8.0 to 10.5 months) in studies assessing hyperfractionated radiotherapy with specified clinical and radiological eligibility criteria applied (<a href="./references#CD010439-bbs2-0024" title="HargraveD ,  BartelsU ,  BouffetE . Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncology2006;7(3):241‐8. ">Hargrave 2006</a>). For <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a>, the median OS and PFS in the hypofractionated radiotherapy group (7.8 months for OS and 6.3 months for PFS) were within the range (7 to 14 months for median OS and 5 to 8 months for median PFS) reported in studies with specified MRI criteria for DIPG (greater than 50% pontine involvement) (<a href="./references#CD010439-bbs2-0030" title="JansenMH , vanVuurdenDG , VandertopWP , KaspersGJ . Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treatment Reviews2012;38(1):27‐35. ">Jansen 2012</a>). Furthermore, the median OS and PFS in <a href="./references#CD010439-bbs2-0002" title="ZaghloulMS , EldebawyE , AhmedS , MousaAG , AminA , RefaatA , et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiotherapy and Oncology2014;111(1):35‐40. ">Zaghloul 2014</a> appeared similar, although slightly different, with that reported in studies focusing on hypofractionated radiotherapy (<a href="./references#CD010439-bbs2-0031" title="JanssensGO ,  GiddingCE ,  Van LindertEJ ,  OldenburgerFR ,  ErasmusCE ,  Schouten‐MeeterenAY ,  etal . The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study. International Journal of Radiation Oncology, Biology, Physics2009;73(3):722‐6. ">Janssens 2009</a>; <a href="./references#CD010439-bbs2-0007" title="NegrettiL , BouchirebK , Levy‐PiedboisC , HabrandJL , DhermainF , KalifaC . Hypofractionated radiotherapy in the treatment of diffuse intrinsic pontine glioma in children: a single institution's experience. Journal of Neuro‐Oncology2011;104(3):773‐7. ">Negretti 2011</a>; <a href="./references#CD010439-bbs2-0005" title="JanssensGO , JansenMH , LauwersSJ , NowakPJ , OldenburgerFR , BouffetE , et al. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched‐cohort analysis. International Journal of Radiation Oncology, Biology, Physics2013;85(2):315‐20. ">Janssens 2013</a>). Based on only one available RCT (Zaghloul 2014), Zaghloul recommended hypofractionated radiotherapy as standard radiotherapy due to the findings that the child and his/her family could spend less than 10% of his/her remaining survival time on treatment, while conventional radiotherapy needs more than double this time, with minimal affection of survival rates (<a href="./references#CD010439-bbs2-0046" title="ZaghloulMS . Has hypofractionated radiotherapy become the standard of care in pediatric DIPG?. Child's Nervous System2015;31(8):1221‐2. ">Zaghloul 2015</a>). In addition, we are waiting for the result from an important ongoing RCT comparing two hypofractionated radiotherapy regimens versus conventional radiotherapy in children with newly diagnosed DIPG (<a href="./references#CD010439-bbs2-0013" title="NCT01878266 . Prospective randomized trial of two hypofractionated radiotherapy regimens versus conventional radiotherapy in pediatric diffuse brainstem glioma. www.clinicaltrials.gov/ct2/show/study/NCT01878266 (accessed 4 April 2016). ">NCT01878266</a>). </p> <p>There are no reviews available discussing the effects of radiotherapy (compared between different radiotherapy techniques or with other therapies) based on RCTs, QRCTs, or CCTs. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010439-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010439-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010439-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.1 Overall survival." data-id="CD010439-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.1 Overall survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.2 Event‐free survival." data-id="CD010439-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.2 Event‐free survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.3 Radiological response." data-id="CD010439-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.3 Radiological response. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.4 Toxicities." data-id="CD010439-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hyperfractionated radiotherapy versus conventional radiotherapy, outcome: 1.4 Toxicities. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Hypofractionated radiotherapy versus conventional radiotherapy, outcome: 2.1 Overall survival." data-id="CD010439-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Hypofractionated radiotherapy versus conventional radiotherapy, outcome: 2.1 Overall survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Hypofractionated radiotherapy versus conventional radiotherapy, outcome: 2.2 Progression‐free survival." data-id="CD010439-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Hypofractionated radiotherapy versus conventional radiotherapy, outcome: 2.2 Progression‐free survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Hypofractionated radiotherapy versus conventional radiotherapy, outcome: 2.3 Toxicities." data-id="CD010439-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Hypofractionated radiotherapy versus conventional radiotherapy, outcome: 2.3 Toxicities. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hyperfractionated radiotherapy versus conventional radiotherapy, Outcome 1 Overall survival." data-id="CD010439-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Hyperfractionated radiotherapy versus conventional radiotherapy, Outcome 1 Overall survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/references#CD010439-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hyperfractionated radiotherapy versus conventional radiotherapy, Outcome 2 Event‐free survival." data-id="CD010439-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Hyperfractionated radiotherapy versus conventional radiotherapy, Outcome 2 Event‐free survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/references#CD010439-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hyperfractionated radiotherapy versus conventional radiotherapy, Outcome 3 Radiological response." data-id="CD010439-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Hyperfractionated radiotherapy versus conventional radiotherapy, Outcome 3 Radiological response. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/references#CD010439-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-CMP-001-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hyperfractionated radiotherapy versus conventional radiotherapy, Outcome 4 Toxicities." data-id="CD010439-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Hyperfractionated radiotherapy versus conventional radiotherapy, Outcome 4 Toxicities. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/references#CD010439-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Hypofractionated radiotherapy versus conventional radiotherapy, Outcome 1 Overall survival." data-id="CD010439-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Hypofractionated radiotherapy versus conventional radiotherapy, Outcome 1 Overall survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/references#CD010439-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-CMP-002-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Hypofractionated radiotherapy versus conventional radiotherapy, Outcome 2 Progression‐free survival." data-id="CD010439-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Hypofractionated radiotherapy versus conventional radiotherapy, Outcome 2 Progression‐free survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/references#CD010439-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010439-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/urn:x-wiley:14651858:media:CD010439:CD010439-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_t/tCD010439-CMP-002-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Hypofractionated radiotherapy versus conventional radiotherapy, Outcome 3 Toxicities." data-id="CD010439-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Hypofractionated radiotherapy versus conventional radiotherapy, Outcome 3 Toxicities. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/references#CD010439-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/media/CDSR/CD010439/image_n/nCD010439-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010439-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hyperfractionated radiotherapy compared with conventional radiotherapy for diffuse brainstem glioma in children and young adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hyperfractionated radiotherapy compared with conventional radiotherapy for diffuse brainstem glioma in children and young adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children and young adults with diffuse brainstem glioma </p> <p><b>Settings:</b> hospital setting in USA and Canada </p> <p><b>Intervention:</b> hyperfractionated radiotherapy </p> <p><b>Comparison:</b> conventional radiotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Conventional radiotherapy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Hyperfractionated radiotherapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HR 1.07 (0.75 to 1.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time‐to‐event data; no assumed risk could be calculated</p> <p>Participants were enrolled between June 1992 and March 1996. All participants were followed until death or October 1997 except 5 participants who were lost during follow‐up </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Progression‐free survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adequate information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Event‐free survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HR 1.26 (0.83 to 1.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>2,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time‐to‐event data; no assumed risk could be calculated</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Neurological response</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adequate information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Radiological response</b> </p> <p>defined as the number of participants with a reduction in tumour size &gt; 50%</p> <p>Follow‐up: 4 or 8 weeks<br/> (median 4 weeks) post treatment </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>333 per 1000<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>313 per 1000<br/> (180 to 543) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.94 (0.54 to 1.63)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>108<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>2,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Toxicities</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>112 or 113</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>2,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Various types of toxicities were evaluated (see text)</p> <p>No significant differences in examined toxicities between the 2 groups</p> <p>For fungal stomatitis, 112 participants were available while for the other toxicities, 113 participants were available </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>HR:</b> hazard ratio; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The assumed risk is based on the prevalence in the control group of the included study. </p> <p><sup>2</sup> Small sample size with a total number of events fewer than 300 (the threshold rule‐of‐thumb value stated in the GRADEpro software). </p> <p><sup>3</sup> Presence of selection bias and other bias was unclear. </p> <p><sup>4</sup> Presence of selection bias, detection bias, and other bias was unclear. </p> <p><sup>5</sup> Presence of selection bias, detection bias, and other bias was unclear; high risk of attrition bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hyperfractionated radiotherapy compared with conventional radiotherapy for diffuse brainstem glioma in children and young adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010439-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Hypofractionated radiotherapy compared with conventional radiotherapy for diffuse brainstem glioma in children and young adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hypofractionated radiotherapy compared with conventional radiotherapy for diffuse brainstem glioma in children and young adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children and young adults with diffuse brainstem glioma </p> <p><b>Settings:</b> Children's Cancer Hospital, Egypt </p> <p><b>Intervention:</b> hypofractionated radiotherapy </p> <p><b>Comparison:</b> conventional radiotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Conventional radiotherapy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Hypofractionated radiotherapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall survival</b> </p> <p>Follow up: mean 9 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HR 1.03 (0.53 to 2.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> moderate<sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time‐to‐event data; no assumed risk could be calculated</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Progression‐free survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HR 1.19 (0.63 to 2.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time‐to‐event data; no assumed risk could be calculated</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Event‐free survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Neurological response</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Radiological response</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on this outcome was provided</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Toxicities</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Various types of toxicities were evaluated (see text)</p> <p>No significant differences in examined toxicities between the 2 groups</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>HR:</b> hazard ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Small sample size with a total number of events fewer than 300 (the threshold rule‐of‐thumb value stated in the GRADEpro software). </p> <p><sup>2</sup> High risk of detection bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Hypofractionated radiotherapy compared with conventional radiotherapy for diffuse brainstem glioma in children and young adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/full#CD010439-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010439-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hyperfractionated radiotherapy versus conventional radiotherapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.75, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Event‐free survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.83, 1.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Radiological response <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.54, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Toxicities <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Platelets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.58 [0.27, 9.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Haemoglobin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.16 [0.34, 29.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Infection (not otherwise specified/unknown)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.22, 5.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Sepsis, bacteria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [0.20, 22.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5 Upper respiratory infection/otitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.43, 2.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6 Abscess</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [0.20, 22.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7 Other bacterial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.15, 7.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.8 Fungal (not otherwise specified/unknown)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.04, 3.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.9 Fungal stomatitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.40, 3.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.10 Alopecia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.44, 7.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.11 Decrease of magnesium (electrolyte imbalance)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.15, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.12 Decrease of sodium (electrolyte imbalance)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [0.20, 22.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.13 Hearing (subjective)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [0.20, 22.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.14 Hearing (objective)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.51 [0.62, 3.68]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hyperfractionated radiotherapy versus conventional radiotherapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/references#CD010439-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010439-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Hypofractionated radiotherapy versus conventional radiotherapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.53, 2.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Progression‐free survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.63, 2.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Toxicities <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Skin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.59, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Hearing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [0.27, 8.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Decreased appetite</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [0.27, 8.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Dysphagia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [0.33, 5.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 Fatigue</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.63, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6 Insomnia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.12, 3.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7 Night mares</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.15, 6.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8 Seizures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.14]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Hypofractionated radiotherapy versus conventional radiotherapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010439.pub2/references#CD010439-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010439.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010439-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010439-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD010439-note-0001">Hrvatski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010439\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010439\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010439\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010439\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010439\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010439.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010439.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010439.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010439.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010439.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726565611"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010439.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726565615"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010439.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e96c29d63f3c9',t:'MTc0MDcyNjU2NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 